These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3226450)
1. Maintenance treatment with desferrioxamine via subcutaneous injections in a patient with HbE thalassaemia. van Deursen CT; Goey SH; Fickers MM Neth J Med; 1988 Oct; 33(3-4):178-81. PubMed ID: 3226450 [No Abstract] [Full Text] [Related]
2. [Longitudinal growth of patients with homozygote beta-thalassemia during continuous subcutaneous infusion of deferoxamine]. Krüger N; Stubbe P; Tillmann W; Schröter W Dtsch Med Wochenschr; 1986 Jan; 111(5):176-81. PubMed ID: 3943469 [TBL] [Abstract][Full Text] [Related]
3. [Continuous subcutaneous deferoxamine infusions in thalassemia major. Improvement in glucose tolerance]. Krüger N; Stubbe P; Tillmann W; Schröter W Dtsch Med Wochenschr; 1986 May; 111(18):698-701. PubMed ID: 3486106 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography. Flynn DM; Hoffbrand AV; Politis D Birth Defects Orig Artic Ser; 1982; 18(7):347-53. PubMed ID: 6819017 [No Abstract] [Full Text] [Related]
5. [Thalassemia major: chelating therapy with deferoxamine]. Abreu de Miani MS; Sanchis de Herrlein MS; Peñalver JA Medicina (B Aires); 1985; 45(3):231-4. PubMed ID: 3841934 [No Abstract] [Full Text] [Related]
6. Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine. Kontopoulou-Griva I; Hatzidimitriou-Papazacharia K; Spiliotopoulou J; Tsagarakis N; Digenopoulou E Birth Defects Orig Artic Ser; 1988; 23(5B):111-6. PubMed ID: 3390532 [No Abstract] [Full Text] [Related]
7. Pharmacist involvement in a deferoxamine education program for patients with Cooley's anemia. Levine HG; Hanan ZI; Gordon FS; Tomasulo WJ Am J Hosp Pharm; 1979 Jun; 36(6):788-90. PubMed ID: 463895 [TBL] [Abstract][Full Text] [Related]
8. Iron loading and thalassemia--experimental successes and practical realities. Weatherall DJ; Pippard MJ; Callender ST N Engl J Med; 1977 Aug; 297(8):445-6. PubMed ID: 560628 [No Abstract] [Full Text] [Related]
9. Intensive iron-chelation in thalassaemia. Pignatti CB; De Stefano P Br Med J; 1978 Nov; 2(6149):1432-3. PubMed ID: 719440 [No Abstract] [Full Text] [Related]
10. Sero-negative rheumatoid arthritis in haemoglobin E thalassaemia. de Silva HJ; Senaratne NL; Goonetilleke AK; de Silva C; Jayawickrama US; Amarasekera LR Ceylon Med J; 1988 Dec; 33(4):131-3. PubMed ID: 3248321 [No Abstract] [Full Text] [Related]
11. Long-term administration of desferrioxamine in thalassaemia major. Seshadri R; Colebatch JH; Gordon P; Ekert H Arch Dis Child; 1974 Aug; 49(8):621-6. PubMed ID: 4278421 [TBL] [Abstract][Full Text] [Related]
12. The simple rubber band technic for slow subcutaneous infusion of desferrioxamine. Hathirat P; Sasanakul W; Areekul S; Chantachum Y; Isarangkura P J Med Assoc Thai; 1984 Feb; 67(2):89-92. PubMed ID: 6736830 [No Abstract] [Full Text] [Related]
16. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias. Pippard MJ; Weatherall DJ Haematologia (Budap); 1984; 17(1):17-24. PubMed ID: 6724353 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously]. Ferrara M; Galdo Capotorti M; Ponte G; Esposito L Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400 [No Abstract] [Full Text] [Related]